<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32731393</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>31</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>9</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Jul</Month><Day>28</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>The Impact of ALS-Associated Genes <i>hnRNPA1</i>, <i>MATR3</i>, <i>VCP</i> and <i>UBQLN2</i> on the Severity of TDP-43 Aggregation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1791</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells9081791</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder, characterized by cytoplasmic inclusions of RNA-binding protein TDP-43. Despite decades of research and identification of more than 50 genes associated with amyotrophic lateral sclerosis (ALS), the cause of TDP-43 translocation from the nucleus and its aggregation in the cytoplasm still remains unknown. Our study addressed the impact of selected ALS-associated genes on TDP-43 aggregation behavior in wild-type and aggregation prone TDP-43 in vitro cell models. These were developed by deleting TDP-43 nuclear localization signal and stepwise shortening its low-complexity region. The SH-SY5Y cells were co-transfected with the constructs of aggregation-prone TDP-43 and wild-type or mutant ALS-associated genes <i>hnRNPA1</i>, <i>MATR3</i>, <i>VCP</i> or <i>UBQLN2</i>. The investigated genes displayed a unique impact on TDP-43 aggregation, generating distinct types of cytoplasmic inclusions, similar to those already described as resembling prion strains, which could represent the basis for neurodegenerative disease heterogeneity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bajc &#x10c;esnik</LastName><ForeName>Ana</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-5418-6600</Identifier><AffiliationInfo><Affiliation>Department of Biotechnology, Jozef Stefan Institute, 1000 Ljubljana, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate School of Biomedicine, Faculty of Medicine, University of Ljubljana, 1000 Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Motaln</LastName><ForeName>Helena</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-0646-7934</Identifier><AffiliationInfo><Affiliation>Department of Biotechnology, Jozef Stefan Institute, 1000 Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rogelj</LastName><ForeName>Boris</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Jozef Stefan Institute, 1000 Ljubljana, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biomedical Research Institute BRIS, 1000 Ljubljana, Slovenia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Chemistry and Chemical Technology, University of Ljubljana, 1000 Ljubljana, Slovenia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071183">Autophagy-Related Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000598624">TARDBP protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071183" MajorTopicYN="N">Autophagy-Related Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="N">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">MATR3</Keyword><Keyword MajorTopicYN="N">TDP-43</Keyword><Keyword MajorTopicYN="N">UBQLN2</Keyword><Keyword MajorTopicYN="N">VCP</Keyword><Keyword MajorTopicYN="N">cytoplasmic aggregation</Keyword><Keyword MajorTopicYN="N">hnRNPA1</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32731393</ArticleId><ArticleId IdType="pmc">PMC7465640</ArticleId><ArticleId IdType="doi">10.3390/cells9081791</ArticleId><ArticleId IdType="pii">cells9081791</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Loughlin F.E., Wilce J.A. TDP-43 and FUS-structural insights into RNA recognition and self-association. Curr. Opin. Struct. Biol. 2019;59:134&#x2013;142. doi: 10.1016/j.sbi.2019.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sbi.2019.07.012</ArticleId><ArticleId IdType="pubmed">31479821</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura A.L., &#x17d;upunski V., Troakes C., Kathe C., Fratta P., Howell M., Gallo J.-M., Hortob&#xe1;gyi T., Shaw C.E., Rogelj B. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration. Brain. 2010;133:1763&#x2013;1771. doi: 10.1093/brain/awq111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq111</ArticleId><ArticleId IdType="pubmed">20472655</ArticleId></ArticleIdList></Reference><Reference><Citation>Modic M., Grosch M., Rot G., Schirge S., Lepko T., Yamazaki T., Lee F.C.Y., Rusha E., Shaposhnikov D., Palo M., et al. Cross-regulation between TDP-43 and paraspeckles promotes pluripotency-differentiation transition. Mol. Cell. 2019;74:951&#x2013;965.e13. doi: 10.1016/j.molcel.2019.03.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.03.041</ArticleId><ArticleId IdType="pmc">PMC6561722</ArticleId><ArticleId IdType="pubmed">31047794</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;talekar M., Yin X., Rebolj K., Darovic S., Troakes C., Mayr M., Shaw C.E., Rogelj B. Proteomic analyses reveal that loss of TDP-43 affects RNA processing and intracellular transport. Neuroscience. 2015;293:157&#x2013;170. doi: 10.1016/j.neuroscience.2015.02.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.02.046</ArticleId><ArticleId IdType="pubmed">25743254</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey J.R., Curk T., Rogelj B., Briese M., Cereda M., Kayikci M., K&#xf6;nig J., Hortob&#xe1;gyi T., Nishimura A.L., Zupunski V., et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 2011;14:452&#x2013;458. doi: 10.1038/nn.2778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2778</ArticleId><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008;319:1668&#x2013;1672. doi: 10.1126/science.1154584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Hergesheimer R.C., Chami A.A., de Assis D.R., Vourc&#x2019;h P., Andres C.R., Corcia P., Lanznaster D., Blasco H. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: A resolution in sight? Brain. 2019;142:1176&#x2013;1194. doi: 10.1093/brain/awz078.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz078</ArticleId><ArticleId IdType="pmc">PMC6487324</ArticleId><ArticleId IdType="pubmed">30938443</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura A.L., Shum C., Scotter E.L., Abdelgany A., Sardone V., Wright J., Lee Y.-B., Chen H.-J., Bilican B., Carrasco M., et al. Allele-specific knockdown of ALS-associated mutant TDP-43 in neural stem cells derived from induced pluripotent stem cells. PLoS ONE. 2014;9:e91269. doi: 10.1371/journal.pone.0091269.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0091269</ArticleId><ArticleId IdType="pmc">PMC3961241</ArticleId><ArticleId IdType="pubmed">24651281</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Rogelj B., Hortob&#xe1;gyi T., De Vos K.J., Nishimura A.L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science. 2009;323:1208&#x2013;1211. doi: 10.1126/science.1165942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165942</ArticleId><ArticleId IdType="pmc">PMC4516382</ArticleId><ArticleId IdType="pubmed">19251628</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell J.C., McGoldrick P., Vance C., Hortobagyi T., Sreedharan J., Rogelj B., Tudor E.L., Smith B.N., Klasen C., Miller C.C.J., et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 2013;125:273&#x2013;288. doi: 10.1007/s00401-012-1043-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1043-z</ArticleId><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Darovic S., Prpar Mihevc S., &#x17d;upunski V., Gun&#x10d;ar G., &#x160;talekar M., Lee Y.-B., Shaw C.E., Rogelj B. Phosphorylation of C-terminal tyrosine residue 526 in FUS impairs its nuclear import. J. Cell. Sci. 2015;128:4151&#x2013;4159. doi: 10.1242/jcs.176602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.176602</ArticleId><ArticleId IdType="pubmed">26403203</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogelj B., Easton L.E., Bogu G.K., Stanton L.W., Rot G., Curk T., Zupan B., Sugimoto Y., Modic M., Haberman N., et al. Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci. Rep. 2012;2:603. doi: 10.1038/srep00603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00603</ArticleId><ArticleId IdType="pmc">PMC3429604</ArticleId><ArticleId IdType="pubmed">22934129</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W., Shatunov A., Dekker A.M., McLaughlin R.L., Diekstra F.P., Pulit S.L., van der Spek R.A.A., V&#xf5;sa U., de Jong S., Robinson M.R., et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis. Nat. Genet. 2016;48:1043&#x2013;1048. doi: 10.1038/ng.3622.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3622</ArticleId><ArticleId IdType="pmc">PMC5556360</ArticleId><ArticleId IdType="pubmed">27455348</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Pioro E.P., Boehringer A., Chia R., Feit H., Renton A.E., Pliner H.A., Abramzon Y., Marangi G., Winborn B.J., et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci. 2014;17:664&#x2013;666. doi: 10.1038/nn.3688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3688</ArticleId><ArticleId IdType="pmc">PMC4000579</ArticleId><ArticleId IdType="pubmed">24686783</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.J., Kim N.C., Wang Y.-D., Scarborough E.A., Moore J., Diaz Z., MacLea K.S., Freibaum B., Li S., Molliex A., et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature. 2013;495:467&#x2013;473. doi: 10.1038/nature11922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11922</ArticleId><ArticleId IdType="pmc">PMC3756911</ArticleId><ArticleId IdType="pubmed">23455423</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Nicholson A.M., Sarkar M., Messing J., Purice M.D., Pottier C., Annu K., Baker M., Perkerson R.B., Kurti A., et al. TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics. Neuron. 2017;95:808&#x2013;816.e9. doi: 10.1016/j.neuron.2017.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.025</ArticleId><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., et al. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68:857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.-X., Chen W., Hong S.-T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult onset ALS and ALS/dementia. Nature. 2011;477:211&#x2013;215. doi: 10.1038/nature10353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F., Yan J., Vemula S.P., Liu E., Yang Y., Chen W., Zheng J.G., Shi Y., Siddique N., Arrat H., et al. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 2011;68:1440&#x2013;1446. doi: 10.1001/archneurol.2011.250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.250</ArticleId><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., et al. Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010;465:223&#x2013;226. doi: 10.1038/nature08971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J., Mediani L., Alberti S., Carra S. ALS and FTD: Where RNA metabolism meets protein quality control. Semin. Cell Dev. Biol. 2020;99:183&#x2013;192. doi: 10.1016/j.semcdb.2019.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2019.06.003</ArticleId><ArticleId IdType="pubmed">31254610</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowicka N., Juranek J., Juranek J.K., Wojtkiewicz J. Risk factors and emerging therapies in amyotrophic lateral sclerosis. Int. J. Mol. Sci. 2019;20 doi: 10.3390/ijms20112616.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20112616</ArticleId><ArticleId IdType="pmc">PMC6600314</ArticleId><ArticleId IdType="pubmed">31141951</ArticleId></ArticleIdList></Reference><Reference><Citation>Babinchak W.M., Surewicz W.K. Liquid-liquid phase separation and its mechanistic role in pathological protein aggregation. J. Mol. Biol. 2020;432:1910&#x2013;1925. doi: 10.1016/j.jmb.2020.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2020.03.004</ArticleId><ArticleId IdType="pmc">PMC7395662</ArticleId><ArticleId IdType="pubmed">32169484</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomes E., Shorter J. The molecular language of membraneless organelles. J. Biol. Chem. 2019;294:7115&#x2013;7127. doi: 10.1074/jbc.TM118.001192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.TM118.001192</ArticleId><ArticleId IdType="pmc">PMC6509512</ArticleId><ArticleId IdType="pubmed">30045872</ArticleId></ArticleIdList></Reference><Reference><Citation>Babinchak W.M., Haider R., Dumm B.K., Sarkar P., Surewicz K., Choi J.-K., Surewicz W.K. The role of liquid&#x2013;liquid phase separation in aggregation of the TDP-43 low-complexity domain. J. Biol. Chem. 2019;294:6306&#x2013;6317. doi: 10.1074/jbc.RA118.007222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.007222</ArticleId><ArticleId IdType="pmc">PMC6484124</ArticleId><ArticleId IdType="pubmed">30814253</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A., Temirov J., Lee J., Coughlin M., Kanagaraj A.P., Kim H.J., Mittag T., Taylor J.P. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163:123&#x2013;133. doi: 10.1016/j.cell.2015.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.015</ArticleId><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt H.B., Barreau A., Rohatgi R. Phase separation-deficient TDP43 remains functional in splicing. Nat. Commun. 2019;10:4890. doi: 10.1038/s41467-019-12740-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12740-2</ArticleId><ArticleId IdType="pmc">PMC6814767</ArticleId><ArticleId IdType="pubmed">31653829</ArticleId></ArticleIdList></Reference><Reference><Citation>Conicella A.E., Zerze G.H., Mittal J., Fawzi N.L. ALS mutations disrupt phase separation mediated by &#x3b1;-helical structure in the TDP-43 low-complexity C-terminal domain. Structure. 2016;24:1537&#x2013;1549. doi: 10.1016/j.str.2016.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2016.07.007</ArticleId><ArticleId IdType="pmc">PMC5014597</ArticleId><ArticleId IdType="pubmed">27545621</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H.-R., Chen T.-C., Hsiao C.-L., Shi L., Chou C.-Y., Huang J. The physical forces mediating self-association and phase-separation in the C-terminal domain of TDP-43. Biochim. Biophys. Acta (BBA)-Proteins Proteom. 2018;1866:214&#x2013;223. doi: 10.1016/j.bbapap.2017.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbapap.2017.10.001</ArticleId><ArticleId IdType="pubmed">28988034</ArticleId></ArticleIdList></Reference><Reference><Citation>Afroz T., Hock E.-M., Ernst P., Foglieni C., Jambeau M., Gilhespy L.A.B., Laferriere F., Maniecka Z., Pl&#xfc;ckthun A., Mittl P., et al. Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation. Nat. Commun. 2017;8 doi: 10.1038/s41467-017-00062-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00062-0</ArticleId><ArticleId IdType="pmc">PMC5491494</ArticleId><ArticleId IdType="pubmed">28663553</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsoi P.S., Choi K.-J., Leonard P.G., Sizovs A., Moosa M.M., MacKenzie K.R., Ferreon J.C., Ferreon A.C.M. The N-terminal domain of ALS-linked TDP-43 assembles without Misfolding. Angew. Chem. Int. Ed. Engl. 2017;56:12590&#x2013;12593. doi: 10.1002/anie.201706769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201706769</ArticleId><ArticleId IdType="pubmed">28833982</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang A., Conicella A.E., Schmidt H.B., Martin E.W., Rhoads S.N., Reeb A.N., Nourse A., Ramirez Montero D., Ryan V.H., Rohatgi R., et al. A single N-terminal phosphomimic disrupts TDP-43 polymerization, phase separation, and RNA splicing. EMBO J. 2018;37:e97452. doi: 10.15252/embj.201797452.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201797452</ArticleId><ArticleId IdType="pmc">PMC5830921</ArticleId><ArticleId IdType="pubmed">29438978</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y.-J., Caulfield T., Xu Y.-F., Gendron T.F., Hubbard J., Stetler C., Sasaguri H., Whitelaw E.C., Cai S., Lee W.C., et al. The dual functions of the extreme N-terminus of TDP-43 in regulating its biological activity and inclusion formation. Hum. Mol. Genet. 2013;22:3112&#x2013;3122. doi: 10.1093/hmg/ddt166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt166</ArticleId><ArticleId IdType="pmc">PMC3699067</ArticleId><ArticleId IdType="pubmed">23575225</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y., Arslan P.E., Won A., Yip C.M., Chakrabartty A. Binding of TDP-43 to the 3&#x2019;UTR of its cognate mRNA enhances its solubility. Biochemistry. 2014;53:5885&#x2013;5894. doi: 10.1021/bi500617x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi500617x</ArticleId><ArticleId IdType="pubmed">25171271</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.-C., Lin K.-F., He R.-Y., Tu P.-H., Koubek J., Hsu Y.-C., Huang J.J.-T. Inhibition of TDP-43 aggregation by nucleic acid binding. PLoS ONE. 2013;8:e64002. doi: 10.1371/journal.pone.0064002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0064002</ArticleId><ArticleId IdType="pmc">PMC3667863</ArticleId><ArticleId IdType="pubmed">23737961</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann J.R., Gleixner A.M., Mauna J.C., Gomes E., DeChellis-Marks M.R., Needham P.G., Copley K.E., Hurtle B., Portz B., Pyles N.J., et al. RNA binding antagonizes neurotoxic phase transitions of TDP-43. Neuron. 2019;102:321&#x2013;338.e8. doi: 10.1016/j.neuron.2019.01.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.01.048</ArticleId><ArticleId IdType="pmc">PMC6472983</ArticleId><ArticleId IdType="pubmed">30826182</ArticleId></ArticleIdList></Reference><Reference><Citation>French R.L., Grese Z.R., Aligireddy H., Dhavale D.D., Reeb A.N., Kedia N., Kotzbauer P.T., Bieschke J., Ayala Y.M. Detection of TAR DNA-binding protein 43 (TDP-43) oligomers as initial intermediate species during aggregate formation. J. Biol. Chem. 2019;294:6696&#x2013;6709. doi: 10.1074/jbc.RA118.005889.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.005889</ArticleId><ArticleId IdType="pmc">PMC6497947</ArticleId><ArticleId IdType="pubmed">30824544</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon D.A., Stepto A., Au W.H., Adachi Y., Diaper D.C., Hall R., Rekhi A., Boudi A., Tziortzouda P., Lee Y.-B., et al. A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-&#x3b1; mediates C9orf72-related neurodegeneration. Brain. 2018;141:2908&#x2013;2924. doi: 10.1093/brain/awy241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awy241</ArticleId><ArticleId IdType="pmc">PMC6158706</ArticleId><ArticleId IdType="pubmed">30239641</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T., Hasegawa M. Prion-like properties of assembled TDP-43. Curr. Opin. Neurobiol. 2020;61:23&#x2013;28. doi: 10.1016/j.conb.2019.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2019.11.018</ArticleId><ArticleId IdType="pubmed">31862626</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y., Kaneko K., Watanabe S., Yamanaka K., Nukina N. A Seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble Transactivation Response Element (TAR) DNA-binding protein-43 inclusions. J. Biol. Chem. 2011;286:18664&#x2013;18672. doi: 10.1074/jbc.M111.231209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.231209</ArticleId><ArticleId IdType="pmc">PMC3099683</ArticleId><ArticleId IdType="pubmed">21454603</ArticleId></ArticleIdList></Reference><Reference><Citation>Porta S., Xu Y., Restrepo C.R., Kwong L.K., Zhang B., Brown H.J., Lee E.B., Trojanowski J.Q., Lee V.M.-Y. Patient-derived frontotemporal lobar degeneration brain extracts induce formation and spreading of TDP-43 pathology in vivo. Nat. Commun. 2018;9:1&#x2013;15. doi: 10.1038/s41467-018-06548-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06548-9</ArticleId><ArticleId IdType="pmc">PMC6181940</ArticleId><ArticleId IdType="pubmed">30310141</ArticleId></ArticleIdList></Reference><Reference><Citation>Nonaka T., Masuda-Suzukake M., Arai T., Hasegawa Y., Akatsu H., Obi T., Yoshida M., Murayama S., Mann D.M.A., Akiyama H., et al. Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell. Rep. 2013;4:124&#x2013;134. doi: 10.1016/j.celrep.2013.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.007</ArticleId><ArticleId IdType="pubmed">23831027</ArticleId></ArticleIdList></Reference><Reference><Citation>Smethurst P., Newcombe J., Troakes C., Simone R., Chen Y.-R., Patani R., Sidle K. In vitro prion-like behaviour of TDP-43 in ALS. Neurobiol. Dis. 2016 doi: 10.1016/j.nbd.2016.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2016.08.007</ArticleId><ArticleId IdType="pmc">PMC5113659</ArticleId><ArticleId IdType="pubmed">27590623</ArticleId></ArticleIdList></Reference><Reference><Citation>Laferri&#xe8;re F., Maniecka Z., P&#xe9;rez-Berlanga M., Hruska-Plochan M., Gilhespy L., Hock E.-M., Wagner U., Afroz T., Boersema P.J., Barmettler G., et al. TDP-43 extracted from frontotemporal lobar degeneration subject brains displays distinct aggregate assemblies and neurotoxic effects reflecting disease progression rates. Nat. Neurosci. 2019;22:65&#x2013;77. doi: 10.1038/s41593-018-0294-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0294-y</ArticleId><ArticleId IdType="pubmed">30559480</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda T., Kitagawa K., Arai K. Phenotypic variability and its pathological basis in amyotrophic lateral sclerosis. Neuropathology. 2020;40:40&#x2013;56. doi: 10.1111/neup.12606.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/neup.12606</ArticleId><ArticleId IdType="pubmed">31802540</ArticleId></ArticleIdList></Reference><Reference><Citation>Velebit J., Horvat A., Smoli&#x10d; T., Prpar Mihevc S., Rogelj B., Zorec R., Vardjan N. Astrocytes with TDP-43 inclusions exhibit reduced noradrenergic cAMP and Ca2+ signaling and dysregulated cell metabolism. Sci. Rep. 2020;10:6003. doi: 10.1038/s41598-020-62864-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62864-5</ArticleId><ArticleId IdType="pmc">PMC7138839</ArticleId><ArticleId IdType="pubmed">32265469</ArticleId></ArticleIdList></Reference><Reference><Citation>Mihevc S.P., Baralle M., Buratti E., Rogelj B. TDP-43 aggregation mirrors TDP-43 knockdown, affecting the expression levels of a common set of proteins. Sci. Rep. 2016;6:33996. doi: 10.1038/srep33996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep33996</ArticleId><ArticleId IdType="pmc">PMC5036055</ArticleId><ArticleId IdType="pubmed">27665936</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S.-C., Albuquerque C.P., Han J.S., Lagier-Tourenne C., Tokunaga S., Zhou H., Cleveland D.W. ALS-associated mutations in TDP-43 increase its stability and promote TDP-43 complexes with FUS/TLS. Proc. Natl. Acad. Sci. USA. 2010;107:13318&#x2013;13323. doi: 10.1073/pnas.1008227107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1008227107</ArticleId><ArticleId IdType="pmc">PMC2922163</ArticleId><ArticleId IdType="pubmed">20624952</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaue-Sawano A., Kurokawa H., Morimura T., Hanyu A., Hama H., Osawa H., Kashiwagi S., Fukami K., Miyata T., Miyoshi H., et al. Visualizing spatiotemporal dynamics of multicellular cell-cycle progression. Cell. 2008;132:487&#x2013;498. doi: 10.1016/j.cell.2007.12.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.12.033</ArticleId><ArticleId IdType="pubmed">18267078</ArticleId></ArticleIdList></Reference><Reference><Citation>Tresse E., Salomons F.A., Vesa J., Bott L.C., Kimonis V., Yao T.-P., Dantuma N.P., Taylor J.P. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy. 2010;6:217&#x2013;227. doi: 10.4161/auto.6.2.11014.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/auto.6.2.11014</ArticleId><ArticleId IdType="pmc">PMC2929010</ArticleId><ArticleId IdType="pubmed">20104022</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleijnen M.F., Shih A.H., Zhou P., Kumar S., Soccio R.E., Kedersha N.L., Gill G., Howley P.M. The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. Mol. Cell. 2000;6:409&#x2013;419. doi: 10.1016/S1097-2765(00)00040-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(00)00040-X</ArticleId><ArticleId IdType="pubmed">10983987</ArticleId></ArticleIdList></Reference><Reference><Citation>Salton M., Elkon R., Borodina T., Davydov A., Yaspo M.-L., Halperin E., Shiloh Y. Matrin 3 Binds and Stabilizes mRNA. PLoS ONE. 2011;6:e23882. doi: 10.1371/journal.pone.0023882.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0023882</ArticleId><ArticleId IdType="pmc">PMC3157474</ArticleId><ArticleId IdType="pubmed">21858232</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaunmuktane Z., Brandner S. Invited review: The role of prion-like mechanisms in neurodegenerative diseases. Neuropathol. Appl. Neurobiol. 2019 doi: 10.1111/nan.12592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12592</ArticleId><ArticleId IdType="pmc">PMC7687189</ArticleId><ArticleId IdType="pubmed">31868945</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii T., Kawakami E., Endo K., Misawa H., Watabe K. Formation and spreading of TDP-43 aggregates in cultured neuronal and glial cells demonstrated by time-lapse imaging. PLoS ONE. 2017;12 doi: 10.1371/journal.pone.0179375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179375</ArticleId><ArticleId IdType="pmc">PMC5466347</ArticleId><ArticleId IdType="pubmed">28599005</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekenstein U., Soreq H. Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: From structural insights to post-transcriptional regulatory roles. Mol. Cell. Neurosci. 2013;56:436&#x2013;446. doi: 10.1016/j.mcn.2012.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2012.12.002</ArticleId><ArticleId IdType="pubmed">23247072</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard J.M., Lin H., Wallace A.J., Kim G., Draper J.M., Haeussler M., Katzman S., Toloue M., Liu Y., Sanford J.R. HNRNPA1 promotes recognition of splice site decoys by U2AF2 in vivo. Genome Res. 2018;28:689&#x2013;698. doi: 10.1101/gr.229062.117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.229062.117</ArticleId><ArticleId IdType="pmc">PMC5932609</ArticleId><ArticleId IdType="pubmed">29650551</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy R., Huang Y., Seckl M.J., Pardo O.E. Emerging roles of hnRNPA1 in modulating malignant transformation. Wiley Interdiscip. Rev. RNA. 2017;8 doi: 10.1002/wrna.1431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wrna.1431</ArticleId><ArticleId IdType="pubmed">28791797</ArticleId></ArticleIdList></Reference><Reference><Citation>Kattuah W., Rogelj B., King A., Shaw C.E., Hortob&#xe1;gyi T., Troakes C. Heterogeneous nuclear Ribonucleoprotein E2 (hnRNP E2) is a component of TDP-43 aggregates specifically in the A and C pathological subtypes of Frontotemporal lobar degeneration. Front. Neurosci. 2019;13 doi: 10.3389/fnins.2019.00551.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.00551</ArticleId><ArticleId IdType="pmc">PMC6558155</ArticleId><ArticleId IdType="pubmed">31213972</ArticleId></ArticleIdList></Reference><Reference><Citation>Gui X., Luo F., Li Y., Zhou H., Qin Z., Liu Z., Gu J., Xie M., Zhao K., Dai B., et al. Structural basis for reversible amyloids of hnRNPA1 elucidates their role in stress granule assembly. Nat. Commun. 2019;10 doi: 10.1038/s41467-019-09902-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09902-7</ArticleId><ArticleId IdType="pmc">PMC6494871</ArticleId><ArticleId IdType="pubmed">31043593</ArticleId></ArticleIdList></Reference><Reference><Citation>Buratti E., Brindisi A., Giombi M., Tisminetzky S., Ayala Y.M., Baralle F.E. TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: An important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J. Biol. Chem. 2005;280:37572&#x2013;37584. doi: 10.1074/jbc.M505557200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M505557200</ArticleId><ArticleId IdType="pubmed">16157593</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasset-Rosa F., Lu S., Yu H., Chen C., Melamed Z., Guo L., Shorter J., Cruz S.D., Cleveland D.W. Cytoplasmic TDP-43 De-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron. 2019;102:339&#x2013;357.e7. doi: 10.1016/j.neuron.2019.02.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.02.038</ArticleId><ArticleId IdType="pmc">PMC6548321</ArticleId><ArticleId IdType="pubmed">30853299</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y., Protter D.S.W., Rosen M.K., Parker R. Formation and maturation of phase separated liquid droplets by RNA binding proteins. Mol. Cell. 2015;60:208&#x2013;219. doi: 10.1016/j.molcel.2015.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2015.08.018</ArticleId><ArticleId IdType="pmc">PMC4609299</ArticleId><ArticleId IdType="pubmed">26412307</ArticleId></ArticleIdList></Reference><Reference><Citation>Salton M., Lerenthal Y., Wang S.-Y., Chen D.J., Shiloh Y. Involvement of Matrin 3 and SFPQ/NONO in the DNA damage response. Cell Cycle. 2010;9:1568&#x2013;1576. doi: 10.4161/cc.9.8.11298.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/cc.9.8.11298</ArticleId><ArticleId IdType="pubmed">20421735</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho M.B., Attig J., Bellora N., K&#xf6;nig J., Hallegger M., Kayikci M., Eyras E., Ule J., Smith C.W.J. Nuclear matrix protein Matrin3 regulates alternative splicing and forms overlapping regulatory networks with PTB. EMBO J. 2015;34:653&#x2013;668. doi: 10.15252/embj.201489852.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201489852</ArticleId><ArticleId IdType="pmc">PMC4365034</ArticleId><ArticleId IdType="pubmed">25599992</ArticleId></ArticleIdList></Reference><Reference><Citation>Attig J., Agostini F., Gooding C., Chakrabarti A.M., Singh A., Haberman N., Zagalak J.A., Emmett W., Smith C.W.J., Luscombe N.M., et al. Heteromeric RNP assembly at LINEs controls lineage-specific RNA processing. Cell. 2018;174:1067&#x2013;1081.e17. doi: 10.1016/j.cell.2018.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.07.001</ArticleId><ArticleId IdType="pmc">PMC6108849</ArticleId><ArticleId IdType="pubmed">30078707</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M., Kim J.R., van Bruggen R., Park J. RNA-binding proteins in amyotrophic lateral sclerosis. Mol. Cells. 2018;41:818&#x2013;829. doi: 10.14348/molcells.2018.0243.</Citation><ArticleIdList><ArticleId IdType="doi">10.14348/molcells.2018.0243</ArticleId><ArticleId IdType="pmc">PMC6182225</ArticleId><ArticleId IdType="pubmed">30157547</ArticleId></ArticleIdList></Reference><Reference><Citation>Maharana S., Wang J., Papadopoulos D.K., Richter D., Pozniakovsky A., Poser I., Bickle M., Rizk S., Guill&#xe9;n-Boixet J., Franzmann T.M., et al. RNA buffers the phase separation behavior of prion-like RNA-binding proteins. Science. 2018;360:918&#x2013;921. doi: 10.1126/science.aar7366.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aar7366</ArticleId><ArticleId IdType="pmc">PMC6091854</ArticleId><ArticleId IdType="pubmed">29650702</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehringer A., Garcia-Mansfield K., Singh G., Bakkar N., Pirrotte P., Bowser R. ALS associated mutations in Matrin 3 alter protein-protein interactions and impede mRNA nuclear export. Sci. Rep. 2017;7 doi: 10.1038/s41598-017-14924-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-14924-6</ArticleId><ArticleId IdType="pmc">PMC5674072</ArticleId><ArticleId IdType="pubmed">29109432</ArticleId></ArticleIdList></Reference><Reference><Citation>Iradi M.C.G., Triplett J.C., Thomas J.D., Davila R., Crown A.M., Brown H., Lewis J., Swanson M.S., Xu G., Rodriguez-Lebron E., et al. Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy. Sci. Rep. 2018;8 doi: 10.1038/s41598-018-21371-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-21371-4</ArticleId><ArticleId IdType="pmc">PMC5840295</ArticleId><ArticleId IdType="pubmed">29511296</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallego-Iradi M.C., Strunk H., Crown A.M., Davila R., Brown H., Rodriguez-Lebron E., Borchelt D.R. N-terminal sequences in Matrin 3 mediate phase separation into droplet-like structures that recruit TDP43 variants lacking RNA binding elements. Lab. Investig. 2019;99:1030&#x2013;1040. doi: 10.1038/s41374-019-0260-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41374-019-0260-7</ArticleId><ArticleId IdType="pmc">PMC6857798</ArticleId><ArticleId IdType="pubmed">31019288</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik A.M., Miguez R.A., Li X., Ho Y.-S., Feldman E.L., Barmada S.J. Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization. eLife. 2018;7:e35977. doi: 10.7554/eLife.35977.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.35977</ArticleId><ArticleId IdType="pmc">PMC6050042</ArticleId><ArticleId IdType="pubmed">30015619</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Y., Meyer H.H., Rapoport T.A. The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature. 2001;414:414652a. doi: 10.1038/414652a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/414652a</ArticleId><ArticleId IdType="pubmed">11740563</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer H., Weihl C.C. The VCP/p97 system at a glance: Connecting cellular function to disease pathogenesis. J. Cell Sci. 2014;127:3877&#x2013;3883. doi: 10.1242/jcs.093831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.093831</ArticleId><ArticleId IdType="pmc">PMC4163641</ArticleId><ArticleId IdType="pubmed">25146396</ArticleId></ArticleIdList></Reference><Reference><Citation>Ye Y., Tang W.K., Zhang T., Xia D. A mighty &#x201c;Protein Extractor&#x201d; of the cell: Structure and function of the p97/CDC48 ATPase. Front. Mol. Biosci. 2017;4 doi: 10.3389/fmolb.2017.00039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2017.00039</ArticleId><ArticleId IdType="pmc">PMC5468458</ArticleId><ArticleId IdType="pubmed">28660197</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter E.L., Vance C., Nishimura A.L., Lee Y.-B., Chen H.-J., Urwin H., Sardone V., Mitchell J.C., Rogelj B., Rubinsztein D.C., et al. Differential roles of the ubiquitin proteasome system and autophagy in the clearance of soluble and aggregated TDP-43 species. J. Cell Sci. 2014;127:1263&#x2013;1278. doi: 10.1242/jcs.140087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.140087</ArticleId><ArticleId IdType="pmc">PMC3953816</ArticleId><ArticleId IdType="pubmed">24424030</ArticleId></ArticleIdList></Reference><Reference><Citation>Song C., Wang Q., Li C.-C.H. Characterization of the aggregation-prevention activity of p97/valosin-containing protein. Biochemistry. 2007;46:14889&#x2013;14898. doi: 10.1021/bi700499j.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi700499j</ArticleId><ArticleId IdType="pubmed">18044963</ArticleId></ArticleIdList></Reference><Reference><Citation>Seguin S.J., Morelli F.F., Vinet J., Amore D., De Biasi S., Poletti A., Rubinsztein D.C., Carra S. Inhibition of autophagy, lysosome and VCP function impairs stress granule assembly. Cell Death Differ. 2014;21:1838&#x2013;1851. doi: 10.1038/cdd.2014.103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2014.103</ArticleId><ArticleId IdType="pmc">PMC4227144</ArticleId><ArticleId IdType="pubmed">25034784</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchan J.R., Kolaitis R.-M., Taylor J.P., Parker R. Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell. 2013;153:1461&#x2013;1474. doi: 10.1016/j.cell.2013.05.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.05.037</ArticleId><ArticleId IdType="pmc">PMC3760148</ArticleId><ArticleId IdType="pubmed">23791177</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Maxwell B.A., Joo J.H., Gwon Y., Messing J., Mishra A., Shaw T.I., Ward A.L., Quan H., Sakurada S.M., et al. ULK1 and ULK2 regulate stress granule disassembly through phosphorylation and activation of VCP/p97. Mol. Cell. 2019;74:742&#x2013;757.e8. doi: 10.1016/j.molcel.2019.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2019.03.027</ArticleId><ArticleId IdType="pmc">PMC6859904</ArticleId><ArticleId IdType="pubmed">30979586</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobra I., Pankivskyi S., Samsonova A., Pastre D., Hamon L. Relation between stress granules and cytoplasmic protein aggregates linked to neurodegenerative diseases. Curr. Neurol. Neurosci. Rep. 2018;18:107. doi: 10.1007/s11910-018-0914-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-018-0914-7</ArticleId><ArticleId IdType="pubmed">30406848</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C., Zennaro E., Fallini C., Weber M., Sommacal A., Buratti E., Silani V., Ratti A. TDP-43 is recruited to stress granules in conditions of oxidative insult. J. Neurochem. 2009;111:1051&#x2013;1061. doi: 10.1111/j.1471-4159.2009.06383.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06383.x</ArticleId><ArticleId IdType="pubmed">19765185</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey C.M., Cenik B., Sephton C.F., Dries D.R., Mayer P., Good S.K., Johnson B.A., Herz J., Yu G. TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol. Cell. Biol. 2011;31:1098&#x2013;1108. doi: 10.1128/MCB.01279-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01279-10</ArticleId><ArticleId IdType="pmc">PMC3067820</ArticleId><ArticleId IdType="pubmed">21173160</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu-Yesucevitz L., Bilgutay A., Zhang Y.-J., Vanderweyde T., Vanderwyde T., Citro A., Mehta T., Zaarur N., McKee A., Bowser R., et al. Tar DNA binding protein-43 (TDP-43) associates with stress granules: Analysis of cultured cells and pathological brain tissue. PLoS ONE. 2010;5:e13250. doi: 10.1371/journal.pone.0013250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013250</ArticleId><ArticleId IdType="pmc">PMC2952586</ArticleId><ArticleId IdType="pubmed">20948999</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald K.K., Aulas A., Destroismaisons L., Pickles S., Beleac E., Camu W., Rouleau G.A., Vande Velde C. TAR DNA-binding protein 43 (TDP-43) regulates stress granule dynamics via differential regulation of G3BP and TIA-1. Hum. Mol. Genet. 2011;20:1400&#x2013;1410. doi: 10.1093/hmg/ddr021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddr021</ArticleId><ArticleId IdType="pubmed">21257637</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Scotter E.L., Nishimura A.L., Troakes C., Mitchell J.C., Kathe C., Urwin H., Manser C., Miller C.C., Hortob&#xe1;gyi T., et al. ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules. Hum. Mol. Genet. 2013;22:2676&#x2013;2688. doi: 10.1093/hmg/ddt117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt117</ArticleId><ArticleId IdType="pmc">PMC3674807</ArticleId><ArticleId IdType="pubmed">23474818</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewey C.M., Cenik B., Sephton C.F., Johnson B.A., Herz J., Yu G. TDP-43 Aggregation in neurodegeneration: Are stress granules the key? Brain Res. 2012;1462:16&#x2013;25. doi: 10.1016/j.brainres.2012.02.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2012.02.032</ArticleId><ArticleId IdType="pmc">PMC3372581</ArticleId><ArticleId IdType="pubmed">22405725</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda S., Tsuchiya H., Kaiho A., Guo Q., Ikeuchi K., Endo A., Arai N., Ohtake F., Murata S., Inada T., et al. Stress- and ubiquitylation-dependent phase separation of the proteasome. Nature. 2020;578:296&#x2013;300. doi: 10.1038/s41586-020-1982-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-1982-9</ArticleId><ArticleId IdType="pubmed">32025036</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K.Y., Yang S., Warraich S.T., Blair I.P. Ubiquilin 2: A component of the ubiquitin&#x2013;proteasome system with an emerging role in neurodegeneration. Int. J. Biochem. Cell Biol. 2014;50:123&#x2013;126. doi: 10.1016/j.biocel.2014.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biocel.2014.02.018</ArticleId><ArticleId IdType="pubmed">24589709</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander E.J., Ghanbari Niaki A., Zhang T., Sarkar J., Liu Y., Nirujogi R.S., Pandey A., Myong S., Wang J. Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. Proc. Natl. Acad. Sci. USA. 2018;115:E11485&#x2013;E11494. doi: 10.1073/pnas.1811997115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1811997115</ArticleId><ArticleId IdType="pmc">PMC6298105</ArticleId><ArticleId IdType="pubmed">30442662</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao T.P., Kolaitis R.-M., Kim H.J., O&#x2019;Donovan K., Martyniak B., Colicino E., Hehnly H., Taylor J.P., Casta&#xf1;eda C.A. Ubiquitin modulates liquid-liquid phase separation of UBQLN2 via disruption of multivalent interactions. Mol. Cell. 2018;69:965&#x2013;978.e6. doi: 10.1016/j.molcel.2018.02.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2018.02.004</ArticleId><ArticleId IdType="pmc">PMC6181577</ArticleId><ArticleId IdType="pubmed">29526694</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao T.P., Martyniak B., Canning A.J., Lei Y., Colicino E.G., Cosgrove M.S., Hehnly H., Casta&#xf1;eda C.A. ALS-linked mutations affect UBQLN2 Oligomerization and phase separation in a position- and amino acid-dependent manner. Structure. 2019;27:937&#x2013;951.e5. doi: 10.1016/j.str.2019.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.str.2019.03.012</ArticleId><ArticleId IdType="pmc">PMC6551275</ArticleId><ArticleId IdType="pubmed">30982635</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P., Brown R.H., Cleveland D.W. Decoding ALS: From genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>